Literature DB >> 26400628

Evaluation of Intracameral Amphotericin B in the Management of Fungal Keratitis: Randomized Controlled Trial.

Namrata Sharma1, Preeti Sankaran1, Tushar Agarwal1, Tarun Arora1, Bhavna Chawla1, Jeewan S Titiyal1, Radhika Tandon1, Gita Satapathy1, Rasik B Vajpayee1,2.   

Abstract

PURPOSE: To evaluate the efficacy and safety of intracameral amphotericin B (ICAMB) in the management of fungal keratitis.
METHODS: In total, 45 eyes with smear-confirmed fungal keratitis with hypopyon were randomized into three treatment groups: Group I (topical antifungal treatment + oral antifungal); Group II (topical antifungal treatment + ICAMB + oral antifungal); and Group III (topical antifungal treatment + drainage of hypopyon + ICAMB + oral antifungal). The main outcome measures were treatment success rate, time to heal, visual acuity gain, and presence of complications.
RESULTS: There were no differences in the treatment success rates (p = 0.66), time to healing (p = 0.18), or mean final visual acuity (logMAR) (p = 0.8) between the three groups. The major complication observed was increased incidence of cataract in group III (40%), though it was statistically insignificant.
CONCLUSIONS: ICAMB does not offer any benefit over topical antifungal therapy when performed alone or associated with drainage of hypopyon.

Entities:  

Keywords:  Fungal keratitis; fungal organisms; intracameral amphotericin; mycotic keratitis; recalcitrant fungal keratitis

Mesh:

Substances:

Year:  2015        PMID: 26400628     DOI: 10.3109/09273948.2015.1057597

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  6 in total

Review 1.  Update on the Management of Infectious Keratitis.

Authors:  Ariana Austin; Tom Lietman; Jennifer Rose-Nussbaumer
Journal:  Ophthalmology       Date:  2017-09-21       Impact factor: 12.079

Review 2.  Review of clinical and basic approaches of fungal keratitis.

Authors:  Jie Wu; Wen-Song Zhang; Jing Zhao; Hong-Yan Zhou
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

3.  Mycotic Keratitis Caused by Fusarium solani sensu stricto (FSSC5): A Case Series.

Authors:  Hazal Boral; Anne van Diepeningen; Elif Erdem; Meltem Yağmur; G Sybren de Hoog; Macit Ilkit; Jacques F Meis; Abdullah M S Al-Hatmi
Journal:  Mycopathologia       Date:  2018-06-21       Impact factor: 2.574

4.  Successful Treatment of Lasiodiplodia theobromae Keratitis - Assessing the Role of Voriconazole.

Authors:  Stephen Tak-Lun Li; Evan Po-Fat Yiu; Angela Hiu-Yan Wong; John Chun-Ting Yeung; Lester Wang-Hon Yu
Journal:  Case Rep Ophthalmol       Date:  2016-10-10

Review 5.  Fusarium Keratitis-Review of Current Treatment Possibilities.

Authors:  Marek Szaliński; Aleksandra Zgryźniak; Izabela Rubisz; Małgorzata Gajdzis; Radosław Kaczmarek; Joanna Przeździecka-Dołyk
Journal:  J Clin Med       Date:  2021-11-23       Impact factor: 4.241

Review 6.  Update on diagnosis and management of refractory corneal infections.

Authors:  Shweta Agarwal; Tanveer A Khan; Murugesan Vanathi; Bhaskar Srinivasan; Geetha Iyer; Radhika Tandon
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.